Third Quarter Start-Ups

In C&EN this week, reports of third quarter start-ups were released. Capital investment across all industries decreased by 31%, and biotech deals decreased from 152 to 108 deals from the second quarter. Though, biotech still claims four spots in the top 10 largest deals for the third-quarter. Despite drops, Mark G. Heesen, president of the National Venture Capital Association reports there will be "reassuring signs of stability".